KFO 274: Platelets - Molecular Mechanisms and Translational Implications
KFO 274: Platelets - Molecular Mechanisms and Translational Implications
批准号:
190538538
负责人:
金额:
$0.0万
依托单位国家:
德国
项目类别:
Clinical Research Units
财政年份:
2011
资助国家:
德国
项目状态:
已结题
起止时间:
2010-12-31 至 2018-12-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Platelets play an important role for haemostasis and thrombosis. Disturbed platelet function causes or aggravates diseases such as myocardial infarction, stroke, atherosclerosis and venous thromboembolisms. Platelet-related diseases represent a major reason and indication for patient admission and treatment, and its incidence is increasing. In recent years, associations of platelets with wound healing, immune defense, inflammation, angiogenesis, tumor progression/ metastasis and regeneration of the diseased tissue have been proposed. Platelets accumulate at site of vascular and tissue injuey and interact with a variety of surrounding target cells. Central cell functions in close proximity are influenced by platelets through direct interactions via specific adhesion receptors or by release of inflammatory mediators (microenvironment). Consequently, platelets bring together cellular and humoral factors at the site of tissue/ vascular injury, channel central aspects of cell function and thereby regulate processe of tissue regeneration and restoration of organ function. Through interaction with cellular and soluble factors, platelets constitute a central point of intersection (thrombocytosome) relevant for a variety of diseases. Platelet research has developed dynamically in recent years concerning clinical as well as basic research. Accordingly, our improved pathophysiological insights enabled us to design new diagnostic and therapeutic approaches, particularly for cardiovascular diseases (translational aspect). Nowadays, many patients benefit from application of new diagnostic tools together with the aid of specific anti-platelet drugs. The aim of the Clinical Research Unit "Platelets - molecular mechanisms and translational implications" is to gain profound insights into integrative mechanisms, how platelets tailor processes of thrombosis/haemostasis, inflammation, angiogenesis, apoptosis or immune defense ("innate immunity") and resulting implications for disease using disease models from cell to mouse to patients. The Clinical Research Unit is focused on disease- and patienten-relevant hypotheses within a interdisciplinary research association. Providing a close cooperation between basic research and clinically relevant studies with patients the Clinical Research Unit in conjunction with our existing structures ("Tübingen Platelet Investigative Consortium, TuePIC") concentrates on the improvement of health care and offers a high degree of translational perspective to facilitate a targeted application of medical treatment (individualized medicine).
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
登录
查看更多内容
UPP1介导的尿苷代谢紊乱通过募集 CD274⁺ 中性粒细胞介导免疫治疗抵抗的机制研究
-
批准号:2026JJ60083
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:赵德泽
-
依托单位:
基于纤维蛋白原yC区功能获得性突变探究Tyr274与血小板αIIbβ3结合的机制及功能研究
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:--
-
批准年份:2024
-
负责人:李蕾
-
依托单位:
基于 CD274 mRNA 阳离子脂质体可溶微针的
构建及其对白癜风经皮治疗作用的研究
-
批准号:TGY24H110004
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:高文彦
-
依托单位:
CD80+CD274+mregDC功能及分化在脓毒症免疫应答紊乱中作用与调控机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:任超
-
依托单位:
ETV4通过转录激活CD274在调控肿瘤免疫逃逸和PD-1抑制剂疗效中的作用机制研究
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:朱涛
-
依托单位:
T细胞调控基因CD274(PD-L1)及TNFRSF14异常通过T/B细胞相互作用促进甲状腺粘膜相关结外边缘区(MALT)淋巴瘤发病的机制研究
-
批准号:--
-
项目类别:--
-
资助金额:30万元
-
批准年份:2021
-
负责人:吴方恬
-
依托单位:
基于新型环己烯结构骨架的长效神经氨酸酶抑制剂抗H274Y和R292K多重耐药流感毒株作用机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:55万元
-
批准年份:2021
-
负责人:熊平
-
依托单位:
CD274调控小胶质细胞参与视网膜色素上皮细胞损伤保护及其分子机制研究
-
批准号:82101109
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:王靓
-
依托单位:
T细胞调控基因CD274(PD-L1)及TNFRSF14异常通过T/B细胞相互作用促进甲状腺粘膜相关结外边缘区(MALT)淋巴瘤发病的机制研究
-
批准号:82100206
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:吴方恬
-
依托单位:
新型H274Y突变型神经氨酸酶抑制剂的设计、合成与抗甲型流感活性研究
-
批准号:81903428
-
项目类别:青年科学基金项目
-
资助金额:21.0万元
-
批准年份:2019
-
负责人:王矿磊
-
依托单位: